Literature DB >> 33351845

A science impact framework to measure impact beyond journal metrics.

Mary D Ari1, John Iskander1, John Araujo1, Christine Casey1, John Kools1, Bin Chen1, Robert Swain1, Miriam Kelly1, Tanja Popovic1.   

Abstract

Measuring the impact of public health science or research is important especially when it comes to health outcomes. Achieving the desired health outcomes take time and may be influenced by several contributors, making attribution of credit to any one entity or effort problematic. Here we offer a science impact framework (SIF) for tracing and linking public health science to events and/or actions with recognized impact beyond journal metrics. The SIF was modeled on the Institute of Medicine's (IOM) Degrees of Impact Thermometer, but differs in that SIF is not incremental, not chronological, and has expanded scope. The SIF recognizes five domains of influence: disseminating science, creating awareness, catalyzing action, effecting change and shaping the future (scope differs from IOM). For public health, the goal is to achieve one or more specific health outcomes. What is unique about this framework is that the focus is not just on the projected impact or outcome but rather the effects that are occurring in real time with the recognition that the measurement field is complex, and it takes time for the ultimate outcome to occur. The SIF is flexible and can be tailored to measure the impact of any scientific effort: from complex initiatives to individual publications. The SIF may be used to measure impact prospectively of an ongoing or new body of work (e.g., research, guidelines and recommendations, or technology) and retrospectively of completed and disseminated work, through linking of events using indicators that are known and have been used for measuring impact. Additionally, linking events offers an approach to both tell our story and also acknowledge other players in the chain of events. The value added by science can easily be relayed to the scientific community, policy makers and the public.

Entities:  

Year:  2020        PMID: 33351845      PMCID: PMC7755179          DOI: 10.1371/journal.pone.0244407

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  58 in total

1.  Early onset neonatal sepsis: the burden of group B Streptococcal and E. coli disease continues.

Authors:  Barbara J Stoll; Nellie I Hansen; Pablo J Sánchez; Roger G Faix; Brenda B Poindexter; Krisa P Van Meurs; Matthew J Bizzarro; Ronald N Goldberg; Ivan D Frantz; Ellen C Hale; Seetha Shankaran; Kathleen Kennedy; Waldemar A Carlo; Kristi L Watterberg; Edward F Bell; Michele C Walsh; Kurt Schibler; Abbot R Laptook; Andi L Shane; Stephanie J Schrag; Abhik Das; Rosemary D Higgins
Journal:  Pediatrics       Date:  2011-04-25       Impact factor: 7.124

2.  Prevention of perinatal group B streptococcal disease--revised guidelines from CDC, 2010.

Authors:  Jennifer R Verani; Lesley McGee; Stephanie J Schrag
Journal:  MMWR Recomm Rep       Date:  2010-11-19

3.  Comparison of the prevalence of shortness, underweight, and overweight among US children aged 0 to 59 months by using the CDC 2000 and the WHO 2006 growth charts.

Authors:  Zuguo Mei; Cynthia L Ogden; Katherine M Flegal; Laurence M Grummer-Strawn
Journal:  J Pediatr       Date:  2008-07-10       Impact factor: 4.406

4.  The maze of impact metrics.

Authors: 
Journal:  Nature       Date:  2013-10-17       Impact factor: 49.962

Review 5.  Group B streptococcal disease in infants: progress in prevention and continued challenges.

Authors:  Jennifer R Verani; Stephanie J Schrag
Journal:  Clin Perinatol       Date:  2010-06       Impact factor: 3.430

6.  Risk of bacterial meningitis in children with cochlear implants.

Authors:  Jennita Reefhuis; Margaret A Honein; Cynthia G Whitney; Shadi Chamany; Eric A Mann; Krista R Biernath; Karen Broder; Susan Manning; Swati Avashia; Marcia Victor; Pamela Costa; Owen Devine; Ann Graham; Coleen Boyle
Journal:  N Engl J Med       Date:  2003-07-31       Impact factor: 91.245

7.  A West Nile virus DNA vaccine induces neutralizing antibody in healthy adults during a phase 1 clinical trial.

Authors:  Julie E Martin; Theodore C Pierson; Sarah Hubka; Steve Rucker; Ingelise J Gordon; Mary E Enama; Charla A Andrews; Qing Xu; Brent S Davis; Martha Nason; Michael Fay; Richard A Koup; Mario Roederer; Robert T Bailer; Phillip L Gomez; John R Mascola; Gwong-Jen J Chang; Gary J Nabel; Barney S Graham
Journal:  J Infect Dis       Date:  2007-12-15       Impact factor: 5.226

8.  Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC.

Authors:  Stephanie Schrag; Rachel Gorwitz; Kristi Fultz-Butts; Anne Schuchat
Journal:  MMWR Recomm Rep       Date:  2002-08-16

Review 9.  A framework for disseminating evidence-based health promotion practices.

Authors:  Jeffrey R Harris; Allen Cheadle; Peggy A Hannon; Mark Forehand; Patricia Lichiello; Eustacia Mahoney; Susan Snyder; Judith Yarrow
Journal:  Prev Chronic Dis       Date:  2011-12-15       Impact factor: 2.830

10.  An organizing framework for translation in public health: the Knowledge to Action Framework.

Authors:  Katherine M Wilson; Teresa J Brady; Catherine Lesesne
Journal:  Prev Chronic Dis       Date:  2011-02-15       Impact factor: 2.830

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.